BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23989197)

  • 1. Blood levels of saturated and monounsaturated fatty acids as markers of de novo lipogenesis and risk of prostate cancer.
    Chavarro JE; Kenfield SA; Stampfer MJ; Loda M; Campos H; Sesso HD; Ma J
    Am J Epidemiol; 2013 Oct; 178(8):1246-55. PubMed ID: 23989197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial Plasma Phospholipid Fatty Acids in the De Novo Lipogenesis Pathway and Total Mortality, Cause-Specific Mortality, and Cardiovascular Diseases in the Cardiovascular Health Study.
    Lai HTM; de Oliveira Otto MC; Lee Y; Wu JHY; Song X; King IB; Psaty BM; Lemaitre RN; McKnight B; Siscovick DS; Mozaffarian D
    J Am Heart Assoc; 2019 Nov; 8(22):e012881. PubMed ID: 31711385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study.
    Ma W; Wu JH; Wang Q; Lemaitre RN; Mukamal KJ; Djoussé L; King IB; Song X; Biggs ML; Delaney JA; Kizer JR; Siscovick DS; Mozaffarian D
    Am J Clin Nutr; 2015 Jan; 101(1):153-63. PubMed ID: 25527759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
    Wu JH; Lemaitre RN; Manichaikul A; Guan W; Tanaka T; Foy M; Kabagambe EK; Djousse L; Siscovick D; Fretts AM; Johnson C; King IB; Psaty BM; McKnight B; Rich SS; Chen YD; Nettleton JA; Tang W; Bandinelli S; Jacobs DR; Browning BL; Laurie CC; Gu X; Tsai MY; Steffen LM; Ferrucci L; Fornage M; Mozaffarian D
    Circ Cardiovasc Genet; 2013 Apr; 6(2):171-83. PubMed ID: 23362303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell MUFAs and risk of coronary artery disease in the Physicians' Health Study.
    Matsumoto C; Matthan NR; Lichtenstein AH; Gaziano JM; Djoussé L
    Am J Clin Nutr; 2013 Sep; 98(3):749-54. PubMed ID: 23824727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective analysis of circulating saturated and monounsaturated fatty acids and risk of non-Hodgkin lymphoma.
    Chiu YH; Bertrand KA; Zhang S; Laden F; Epstein MM; Rosner BA; Chiuve S; Campos H; Giovannucci EL; Chavarro JE; Birmann BM
    Int J Cancer; 2018 Oct; 143(8):1914-1922. PubMed ID: 29756258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial Biomarkers of De Novo Lipogenesis Fatty Acids and Incident Heart Failure in Older Adults: The Cardiovascular Health Study.
    Lee Y; Lai HTM; de Oliveira Otto MC; Lemaitre RN; McKnight B; King IB; Song X; Huggins GS; Vest AR; Siscovick DS; Mozaffarian D
    J Am Heart Assoc; 2020 Feb; 9(4):e014119. PubMed ID: 32020839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood fatty acid patterns are associated with prostate cancer risk in a prospective nested case-control study.
    Yang M; Ayuningtyas A; Kenfield SA; Sesso HD; Campos H; Ma J; Stampfer MJ; Chavarro JE
    Cancer Causes Control; 2016 Sep; 27(9):1153-61. PubMed ID: 27488836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma fatty acids in de novo lipogenesis pathway are associated with diabetogenic indicators among adults: NHANES 2003-2004.
    Yu EA; Hu PJ; Mehta S
    Am J Clin Nutr; 2018 Sep; 108(3):622-632. PubMed ID: 30535092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect Modification by Time Since Blood Draw on the Association Between Circulating Fatty Acids and Prostate Cancer Risk.
    Yang M; Sesso HD; Colditz GA; Ma J; Stampfer MJ; Chavarro JE
    J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27297429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk.
    Bassett JK; Severi G; Hodge AM; MacInnis RJ; Gibson RA; Hopper JL; English DR; Giles GG
    Int J Cancer; 2013 Oct; 133(8):1882-91. PubMed ID: 23575905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of trans-fatty acid levels in blood and risk of prostate cancer.
    Chavarro JE; Stampfer MJ; Campos H; Kurth T; Willett WC; Ma J
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):95-101. PubMed ID: 18199715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between carbohydrate intake and fatty acids in the de novo lipogenic pathway in serum phospholipids and adipose tissue in a population of Swedish men.
    Alsharari ZD; Leander K; Sjögren P; Carlsson A; Cederholm T; de Faire U; Hellenius ML; Marklund M; Risérus U
    Eur J Nutr; 2020 Aug; 59(5):2089-2097. PubMed ID: 31350637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese.
    Zong G; Zhu J; Sun L; Ye X; Lu L; Jin Q; Zheng H; Yu Z; Zhu Z; Li H; Sun Q; Lin X
    Am J Clin Nutr; 2013 Aug; 98(2):319-26. PubMed ID: 23803879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.
    Imamura F; Fretts AM; Marklund M; Ardisson Korat AV; Yang WS; Lankinen M; Qureshi W; Helmer C; Chen TA; Virtanen JK; Wong K; Bassett JK; Murphy R; Tintle N; Yu CI; Brouwer IA; Chien KL; Chen YY; Wood AC; Del Gobbo LC; Djousse L; Geleijnse JM; Giles GG; de Goede J; Gudnason V; Harris WS; Hodge A; Hu F; ; Koulman A; Laakso M; Lind L; Lin HJ; McKnight B; Rajaobelina K; Riserus U; Robinson JG; Samieri C; Senn M; Siscovick DS; Soedamah-Muthu SS; Sotoodehnia N; Sun Q; Tsai MY; Tuomainen TP; Uusitupa M; Wagenknecht LE; Wareham NJ; Wu JHY; Micha R; Lemaitre RN; Mozaffarian D; Forouhi NG
    PLoS Med; 2020 Jun; 17(6):e1003102. PubMed ID: 32530938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective evaluation of plasma phospholipid fatty acids and breast cancer risk in the EPIC study.
    Chajès V; Assi N; Biessy C; Ferrari P; Rinaldi S; Slimani N; Lenoir GM; Baglietto L; His M; Boutron-Ruault MC; Trichopoulou A; Lagiou P; Katsoulis M; Kaaks R; Kühn T; Panico S; Pala V; Masala G; Bueno-de-Mesquita HB; Peeters PH; van Gils C; Hjartåker A; Standahl Olsen K; Borgund Barnung R; Barricarte A; Redondo-Sanchez D; Menéndez V; Amiano P; Wennberg M; Key T; Khaw KT; Merritt MA; Riboli E; Gunter MJ; Romieu I
    Ann Oncol; 2017 Nov; 28(11):2836-2842. PubMed ID: 28950350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Erythrocyte Fatty Acids in the De Novo Lipogenesis Pathway with Proxies of Liver Fat Accumulation in the EPIC-Potsdam Study.
    Jacobs S; Jäger S; Jansen E; Peter A; Stefan N; Boeing H; Schulze MB; Kröger J
    PLoS One; 2015; 10(5):e0127368. PubMed ID: 25984792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study.
    Wu JH; Lemaitre RN; Imamura F; King IB; Song X; Spiegelman D; Siscovick DS; Mozaffarian D
    Am J Clin Nutr; 2011 Aug; 94(2):431-8. PubMed ID: 21697077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary long-chain unsaturated fatty acids acutely and differently reduce the activities of lipogenic enzymes and of citrate carrier in rat liver.
    Gnoni A; Giudetti AM
    J Physiol Biochem; 2016 Sep; 72(3):485-94. PubMed ID: 27312217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of plasma fatty acids and risk of prostate cancer.
    Gann PH; Hennekens CH; Sacks FM; Grodstein F; Giovannucci EL; Stampfer MJ
    J Natl Cancer Inst; 1994 Feb; 86(4):281-6. PubMed ID: 8158682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.